Literature DB >> 23146565

Changes in body weight and tuberculosis treatment outcome in Viet Nam.

N B Hoa1, J M Lauritsen, H L Rieder.   

Abstract

SETTING: National Tuberculosis Programme, Viet Nam, 2008.
OBJECTIVE: To assess the relationship between changes in body weight and tuberculosis (TB) treatment outcome.
METHODS: All treatment cards of patients from a sample of 30 randomly selected treatment units in the country were analysed.
RESULTS: Of 2609 patients, 2506 (96.1%) had a successful treatment outcome. The median body weight of all patients at diagnosis was 46.0 kg (25th and 75th percentiles 41-51). New sputum smear-positive TB patients with a successful treatment outcome gained an average of 2.6 kg during treatment. Patients with weight loss during the first 2 months of treatment were more likely to have an unsuccessful outcome than patients without (OR 4.9, 95%CI 3.0-7.9). Patients weighing <40 kg at treatment start who gained more than 5% of their body weight after 2 months of treatment had a significantly smaller risk of an unsuccessful treatment outcome than patients who did not (OR 0.2, 95%CI 0.05-0.96).
CONCLUSIONS: Patients failing to gain weight or losing weight, particularly during the first 2 months of treatment, require particular attention, as they appear to be at an increased risk of unsuccessful treatment outcome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23146565     DOI: 10.5588/ijtld.12.0369

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  16 in total

1.  Weight gain and response to treatment for multidrug-resistant tuberculosis.

Authors:  Ma Tarcela Gler; Ruffy Guilatco; Janice C Caoili; Julia Ershova; Peter Cegielski; John L Johnson
Journal:  Am J Trop Med Hyg       Date:  2013-09-09       Impact factor: 2.345

2.  Nutritional status of HIV-infected women with tuberculosis in Dar es Salaam, Tanzania.

Authors:  M Bakari; J Wamsele; T MacKenzie; I Maro; J Kimario; S Ali; S Dowla; K Hendricks; Z Lukmanji; N M Neke; R Waddell; M Matee; K Pallangyo; C F von Reyn
Journal:  Public Health Action       Date:  2013-09-21

3.  Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.

Authors:  Lauren S Peetluk; Peter F Rebeiro; Marcelo Cordeiro-Santos; Afranio Kritski; Bruno B Andrade; Betina Durovni; Solange Calvacante; María B Arriaga; Megan M Turner; Marina C Figueiredo; Valeria C Rolla; Timothy R Sterling
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

4.  The Influence of Mining and Human Immunodeficiency Virus Infection Among Patients Admitted for Retreatment of Tuberculosis in Northern Tanzania.

Authors:  Stellah G Mpagama; Isaack A Lekule; Alexander W Mbuya; Riziki M Kisonga; Scott K Heysell
Journal:  Am J Trop Med Hyg       Date:  2015-05-26       Impact factor: 2.345

5.  Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.

Authors:  N B Bhatt; C Barau; A Amin; E Baudin; B Meggi; C Silva; V Furlan; B Grinsztejn; A Barrail-Tran; M Bonnet; A M Taburet
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

6.  Structural equation modeling of latent growth curves of weight gain among treated tuberculosis patients.

Authors:  Mahalingam Vasantha; Perumal Venkatesan
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

7.  Improvement in plasma drug activity during the early treatment interval among Tanzanian patients with multidrug-resistant tuberculosis.

Authors:  Norah D Ndusilo; Scott K Heysell; Stellah G Mpagama; Jean Gratz; Farida H Segesela; Saumu J Pazia; Xin-Qun Wang; Eric R Houpt; Gibson S Kibiki
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

8.  Tuberculosis treatment outcomes of six and eight month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study.

Authors:  Abyot Asres; Degu Jerene; Wakgari Deressa
Journal:  BMC Infect Dis       Date:  2016-11-08       Impact factor: 3.090

9.  L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.

Authors:  Anna P Ralph; Govert Waramori; Gysje J Pontororing; Enny Kenangalem; Andri Wiguna; Emiliana Tjitra; Dina B Lolong; Tsin W Yeo; Mark D Chatfield; Retno K Soemanto; Ivan Bastian; Richard Lumb; Graeme P Maguire; John Eisman; Ric N Price; Peter S Morris; Paul M Kelly; Nicholas M Anstey
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

10.  Tuberculosis outcomes in Papua, Indonesia: the relationship with different body mass index characteristics between papuan and non-Papuan ethnic groups.

Authors:  Enny Kenangalem; Govert Waramori; Gysje J Pontororing; Emiliana Tjitra; Graeme Maguire; Paul M Kelly; Nicholas M Anstey; Anna P Ralph
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.